Mineralys Therapeutics, Inc.
MLYS
$25.02
-$0.71-2.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 656.64M | 593.63M | 324.92M | 343.03M | 198.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.75M | 6.17M | 10.35M | 11.48M | 7.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 661.39M | 599.80M | 335.27M | 354.51M | 205.35M |
|
|
|||||
| Total Current Assets | 661.39M | 599.80M | 335.27M | 354.51M | 205.35M |
| Net Property, Plant & Equipment | 38.00K | 7.00K | 22.00K | 38.00K | 53.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 382.00K | 144.00K | 433.00K | 397.00K | 499.00K |
| Total Assets | 661.81M | 599.95M | 335.72M | 354.94M | 205.90M |
|
|
|||||
| Total Accounts Payable | 2.02M | 1.12M | 3.16M | 373.00K | 479.00K |
| Total Accrued Expenses | 13.10M | 22.40M | 19.01M | 13.01M | 14.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.11M | 23.52M | 22.17M | 13.39M | 14.65M |
|
|
|||||
| Total Current Liabilities | 15.11M | 23.52M | 22.17M | 13.39M | 14.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.11M | 23.52M | 22.17M | 13.39M | 14.65M |
|
|
|||||
| Common Stock & APIC | 1.10B | 1.00B | 701.55M | 686.28M | 493.78M |
| Retained Earnings | -457.17M | -424.94M | -388.00M | -344.73M | -302.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 646.69M | 576.43M | 313.55M | 341.56M | 191.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 646.69M | 576.43M | 313.55M | 341.56M | 191.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 646.69M | 576.43M | 313.55M | 341.56M | 191.26M |
|
|
|||||